Role of Human Papillomavirus Infection in the Development of Prostate Carcinoma and Benign Prostatic Hyperplasia

References (36)

1. 1 Cancer-related inflammation [DOI]
2. 2 Prostate carcinogenesis and inflammation: emerging insights [DOI]
3. 3 Meta-Analysis of Measures of Sexual Activity and Prostate Cancer [DOI]
4. 4 A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms [DOI]
5. 5 Development of a Sensitive and Specific Assay Combining Multiplex PCR and DNA Microarray Primer Extension To Detect High-Risk Mucosal Human Papillomavirus Types [DOI]
6. 6 Identification of viral infections in the prostate and evaluation of their association with cancer [DOI]
7. 7 Sequence Variants in Toll-Like Receptor Gene Cluster (TLR6-TLR1-TLR10) and Prostate Cancer Risk [DOI]
8. 8 Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections [DOI]
9. 9 Inflammation, infection, and prostate cancer [DOI]
10. 10 Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina [DOI]
11. 11 Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study.
12. 12 No link between viral findings in the prostate and subsequent cancer development [DOI]
13. 13 Implication of high risk Human papillomavirus HR-HPV infection in prostate cancer in Indian population- A pioneering case-control analysis [DOI]
14. 14 Thirty years of research on infection and prostate cancer: No conclusive evidence for a link. A systematic review [DOI]
15. 15 No Evidence for Infection of UK Prostate Cancer Patients with XMRV, BK Virus, Trichomonas vaginalis or Human Papilloma Viruses [DOI]
16. 16 Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas.
17. 17 A multifaceted study of human papillomavirus and prostate carcinoma [DOI]
18. 18 Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers.
19. 19 Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: A prospective study [DOI]
20. 20 Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized [DOI]
21. 21 Human Papillomavirus Types 16, 18, and 31 Serostatus and Prostate Cancer Risk in the Prostate Cancer Prevention Trial [DOI]
22. 22 Detection of infectious organisms in archival prostate cancer tissues [DOI]
23. 23 Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients [DOI]
24. 24 Biological and Clinical Basis for Molecular Studies of Interferons [DOI]
25. 25 Detection of human papillomavirus DNA in prostate gland tissue by using the polymerase chain reaction amplification assay [DOI]
26. 26 Detection of human papillomavirus (HPV) DNA in archival specimens of benign prostatic hyperplasia and prostatic cancer using a highly sensitive nested PCR method [DOI]
27. 27 Low frequency of human papillomavirus detection in prostate tissue from individuals from Northern Brazil [DOI]
28. 28 Involvement of human papillomavirus infections in prostate cancer progression [DOI]
29. 29 Lack of detection of human papillomavirus DNA in prostate carcinomas in patients from northeastern Brazil [DOI]
30. 30 Human Papillomavirus and Herpes Virus DNA are not Detected in Benign and Malignant Prostatic Tissue using the Polymerase Chain Reaction [DOI]
31. 31 Specific Cytogenetic Aberrations in Two Novel Human Prostatic Cell Lines Immortalized by Human Papillomavirus Type 18 DNA [DOI]
32. 32 Absence of human papillomavirus sequences in early stage prostate cancer.
33. 33 The role of human papillomavirus Infection in prostate carcinoma [DOI]
34. 34 A multifaceted study of human papillomavirus and prostate carcinoma [DOI]
35. 35 Occurrence of human papillomavirus types 16 and 18 in benign prostatic hyperplasia tissues of Saudi patients. [DOI]
36. 36 Sequence Variants in Toll-Like Receptor Gene Cluster (TLR6-TLR1-TLR10) and Prostate Cancer Risk [DOI]

Cited by 3

Showing 1 of 3 known citations — external sources report more than can currently be individually listed.

Related research

• Cytological Evaluation of Urinary Samples among Vesicovaginal Fistula Patients in National Obstetrics Fistula Centre, Southeastern Nigeria — shares topic coverage
• Retrospective Analysis of Cancer Cervix at Awal Bros Batam Hospital in 2020-2022 — shares topic coverage
• Perception and Acceptance of Human Papilloma Virus Vaccine by Mothers in Owerri, Nigeria: A Cross Sectional Study — shares topic coverage
• Human Papilloma Virus Vaccination Knowledge and Willingness to Vaccinate Adolescents among Parents Attending an Out-Patient Clinic in South-South Nigeria — shares topic coverage
• Seroprevalence of Human Papillomavirus Type 16 Immunoglobulin G Antibodies (HPV 16-IgG) among Women Attending General Hospital Kagarko, Kagarko Lga, Kaduna State — shares topic coverage